HB3532 - Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2023
US Congress - 118th Congress
Last updated over 1 year ago
0 Co-Sponsors
To amend the Federal Food, Drug, and Cosmetic Act to provide for reciprocal marketing approval of certain drugs, biological products, and devices that are authorized to be lawfully marketed abroad, and for other purposes.
STATUS
Introduced
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity now